Chronic villitis of unknown etiology
Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophistica...
Gespeichert in:
Veröffentlicht in: | European journal of obstetrics & gynecology and reproductive biology 2008-01, Vol.136 (1), p.9-15 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15 |
---|---|
container_issue | 1 |
container_start_page | 9 |
container_title | European journal of obstetrics & gynecology and reproductive biology |
container_volume | 136 |
creator | Boog, Georges |
description | Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins. |
doi_str_mv | 10.1016/j.ejogrb.2007.06.018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70187480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0301211507002849</els_id><sourcerecordid>70187480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</originalsourceid><addsrcrecordid>eNqFkc1u1DAURi0EotPCGyA0C8ou4fontrNBQqNSkCqxKKytxLkuTj1xsZOiefs6mpEqscEbb8732fdcQt5RqClQ-WmscYx3qa8ZgKpB1kD1C7KhWrFKyUa8JBvgQCtGaXNGznMeoRzO29fkjCqpuRZyQz7sfqc4ebt99CH42edtdNtlup_i32mLs48h3h3ekFeuCxnfnu4L8uvr1c_dt-rmx_X33ZebygrRzBWXQg-N6htOXU-p7J1rOWWuZVag1gobqS1oMTgBTiNzlAIOHZcMHXNc8wvy8dj7kOKfBfNs9j5bDKGbMC7ZqDKiEhoKKI6gTTHnhM48JL_v0sFQMKsdM5qjHbPaMSBNiZbY-1P_0u9xeA6ddBTg8gR02XbBpW6yPj9zbat1S9f3Px85LDYePSaTrcfJ4uAT2tkM0f_vJ_8W2ODLGrpwjwfMY1zSVEwbajIzYG7XTa6LBAXAtGj5E48Al-4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70187480</pqid></control><display><type>article</type><title>Chronic villitis of unknown etiology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Boog, Georges</creator><creatorcontrib>Boog, Georges</creatorcontrib><description>Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2007.06.018</identifier><identifier>PMID: 17683846</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; Chorionic Villi - pathology ; Chronic villitis of unknown etiology ; Diseases of mother, fetus and pregnancy ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Inflammation ; Medical sciences ; Obstetrics and Gynecology ; Placenta Diseases - etiology ; Placenta Diseases - prevention & control ; Pregnancy ; Pregnancy complications ; Pregnancy Complications - etiology ; Pregnancy Complications - prevention & control ; Pregnancy. Fetus. Placenta ; Prevention ; Recurrences ; Risk Factors ; Secondary Prevention</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 2008-01, Vol.136 (1), p.9-15</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2007 Elsevier Ireland Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</citedby><cites>FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0301211507002849$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19988910$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17683846$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boog, Georges</creatorcontrib><title>Chronic villitis of unknown etiology</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.</description><subject>Biological and medical sciences</subject><subject>Chorionic Villi - pathology</subject><subject>Chronic villitis of unknown etiology</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Medical sciences</subject><subject>Obstetrics and Gynecology</subject><subject>Placenta Diseases - etiology</subject><subject>Placenta Diseases - prevention & control</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Pregnancy Complications - etiology</subject><subject>Pregnancy Complications - prevention & control</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Prevention</subject><subject>Recurrences</subject><subject>Risk Factors</subject><subject>Secondary Prevention</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAURi0EotPCGyA0C8ou4fontrNBQqNSkCqxKKytxLkuTj1xsZOiefs6mpEqscEbb8732fdcQt5RqClQ-WmscYx3qa8ZgKpB1kD1C7KhWrFKyUa8JBvgQCtGaXNGznMeoRzO29fkjCqpuRZyQz7sfqc4ebt99CH42edtdNtlup_i32mLs48h3h3ekFeuCxnfnu4L8uvr1c_dt-rmx_X33ZebygrRzBWXQg-N6htOXU-p7J1rOWWuZVag1gobqS1oMTgBTiNzlAIOHZcMHXNc8wvy8dj7kOKfBfNs9j5bDKGbMC7ZqDKiEhoKKI6gTTHnhM48JL_v0sFQMKsdM5qjHbPaMSBNiZbY-1P_0u9xeA6ddBTg8gR02XbBpW6yPj9zbat1S9f3Px85LDYePSaTrcfJ4uAT2tkM0f_vJ_8W2ODLGrpwjwfMY1zSVEwbajIzYG7XTa6LBAXAtGj5E48Al-4</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Boog, Georges</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Chronic villitis of unknown etiology</title><author>Boog, Georges</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-3648d57b531fb116bff9312f92c4e887e568c084df40f8e2f110eda362ef2f383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Chorionic Villi - pathology</topic><topic>Chronic villitis of unknown etiology</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Medical sciences</topic><topic>Obstetrics and Gynecology</topic><topic>Placenta Diseases - etiology</topic><topic>Placenta Diseases - prevention & control</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Pregnancy Complications - etiology</topic><topic>Pregnancy Complications - prevention & control</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Prevention</topic><topic>Recurrences</topic><topic>Risk Factors</topic><topic>Secondary Prevention</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boog, Georges</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boog, Georges</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic villitis of unknown etiology</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>136</volume><issue>1</issue><spage>9</spage><epage>15</epage><pages>9-15</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>Abstract The diagnosis of chronic villitis of unknown etiology (CVUE), characterized by focal areas of inflammation with mononuclear cells and areas of fibrinoid necrosis in chorionic villi, can only be set-up after exclusion of a latent maternal-fetal transmission of infectious agents by sophisticated techniques such as polymerase chain reaction. Significant associations of CVUE with maternal body mass index, multigravidity and ethnicity were reported. While a fetal origin of the inflammatory cells has been evoked, there are many more arguments drawn from histopathology and immunohistology for a maternal immune response against the foreign fetal allograft. CVUE is detected in 7–33% of placentas, mainly after idiopathic intrauterine growth retardation, unexplained prematurity, preeclampsia, perinatal asphyxia and intrauterine fetal death. CVUE is also more frequent in pregnancies affected by autoimmune or alloimmune diseases. Considering the high rate of recurrences after an index case of CVUE, we would suggest to associate aspirine and corticosteroids in further pregnancies, a regimen that was successful in our experience but must be confirmed by other studies. The same is true for the alleviated inflammatory immunologic response recently obtained by a weekly use of maternal intravenous immunoglobulins.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>17683846</pmid><doi>10.1016/j.ejogrb.2007.06.018</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-2115 |
ispartof | European journal of obstetrics & gynecology and reproductive biology, 2008-01, Vol.136 (1), p.9-15 |
issn | 0301-2115 1872-7654 |
language | eng |
recordid | cdi_proquest_miscellaneous_70187480 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Chorionic Villi - pathology Chronic villitis of unknown etiology Diseases of mother, fetus and pregnancy Female Gynecology. Andrology. Obstetrics Humans Inflammation Medical sciences Obstetrics and Gynecology Placenta Diseases - etiology Placenta Diseases - prevention & control Pregnancy Pregnancy complications Pregnancy Complications - etiology Pregnancy Complications - prevention & control Pregnancy. Fetus. Placenta Prevention Recurrences Risk Factors Secondary Prevention |
title | Chronic villitis of unknown etiology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A39%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20villitis%20of%20unknown%20etiology&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Boog,%20Georges&rft.date=2008-01-01&rft.volume=136&rft.issue=1&rft.spage=9&rft.epage=15&rft.pages=9-15&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/j.ejogrb.2007.06.018&rft_dat=%3Cproquest_cross%3E70187480%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70187480&rft_id=info:pmid/17683846&rft_els_id=1_s2_0_S0301211507002849&rfr_iscdi=true |